相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Symptom onset in autosomal dominant Alzheimer disease A systematic review and meta-analysis
Davis C. Ryman et al.
NEUROLOGY (2014)
PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease
Herminia D. Rosas et al.
NEUROLOGY (2014)
The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease
Megan Hooper et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
S. M. Mills et al.
REVUE NEUROLOGIQUE (2013)
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
Krista L. Moulder et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Longitudinal Assessment of A beta and Cognition in Aging and Alzheimer Disease
Victor L. Villemagne et al.
ANNALS OF NEUROLOGY (2011)
Testing the Right Target and Right Drug at the Right Stage
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
Joshua D. Grill et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
Commentary on A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: Opportunities and challenges
John M. Ringman et al.
ALZHEIMERS & DEMENTIA (2009)
Attitudes and Knowledge About Genetic Testing Before and After Finding the Disease-Causing Mutation Among Individuals at High Risk for Familial, Early-Onset Alzheimer's Disease
Beatriz Marcheco-Teruel et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2009)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
Biochemical markers in persons with preclinical familial Alzheimer disease
J. M. Ringman et al.
NEUROLOGY (2008)
Disease-modifying therapies for Alzheimer disease
Jeffrey L. Cummings et al.
NEUROLOGY (2007)
Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapy
N. Dahodwala et al.
PARKINSONISM & RELATED DISORDERS (2007)
Prevention of Alzheimer disease
Leon J. Thal
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: A review
JM Ringman
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: A naturally-occuring experiment
J Mouchawar et al.
GENETICS IN MEDICINE (2005)
Ethical principles and pitfalls of genetic testing for dementia
P Hedera
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2001)
Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia
EJ Steinbart et al.
ARCHIVES OF NEUROLOGY (2001)
分享论文
